Radio and PodcastLive Radio & Podcasts
Science & Medicine
Pan-Cancer Analysis Identifies Buckwheat-Derived Compound as Potential AKT1 Drug-Design Candidate
BUFFALO, NY – October 14, 2026 – A new paper was in Volume 17 of on October 12, 2026, titled “Integrative pan-cancer analysis of AKT1 and structure-based drug design by buckwheat derived compounds.” The study examined th...
Related Episodes
Continue listening to more episodes from Oncotarget.
Epigenetic Silencing of TRAIL-R2 Is Linked to Aggressive Features in Breast Cancer
Oct 6, 2026 - 00:14:04
Gut Microbiome Emerges as a Potential Partner in Precision Cancer Therapy
Sep 28, 2026 - 00:06:09
DHHC3 Helps Melanoma Tumors Evade Antitumor Immunity
Sep 23, 2026 - 00:11:16
Restoring MHC-I Expression Could Strengthen Immune Responses Against CNS Cancers
Sep 9, 2026 - 00:06:42
Therapeutic HPV Vaccine PepCan Tested for Preventing Head and Neck Cancer Recurrence
Sep 8, 2026 - 00:12:46
Oncotarget Supports WIN 2026 Symposium Advancing Precision Oncology
Sep 8, 2026 - 00:02:33